+++++
NCT00872417
+++++
The DT
aim NN
of IN
this DT
study NN
was VBD
to TO
investigate VB
the DT
impact NN
of IN
a DT
tenofovir JJ
disoproxil JJ
fumarate NN
-LRB- -LRB-
TDF NNP
-RRB- -RRB-
plus CC
ritonavir-boosted JJ
protease NN
inhibitor NN
-LRB- -LRB-
PI\/r NNP
-RRB- -RRB-
regimen NN
on IN
renal JJ
function NN
in IN
Chinese JJ
HIV-infected JJ
patients.Seventy-five JJ
HIV-1 NN
infected JJ
patients NNS
failing VBG
first-line JJ
antiretroviral JJ
therapy NN
-LRB- -LRB-
ART NNP
-RRB- -RRB-
comprised VBN
the DT
TDF+PI NNP
\/ NNP
r NN
group NN
. .
Seventy-five JJ
HIV-1 NN
infected VBN
patients NNS
matched VBN
for IN
gender NN
, ,
age NN
, ,
and CC
renal JJ
function NN
made VBD
up RP
the DT
control NN
. .
All DT
subjects NNS
completed VBD
follow-up JJ
visits NNS
over IN
48 CD
weeks NNS
. .
CD4 NN
cell NN
count NN
, ,
plasma NN
HIV-1 NN
viral JJ
load NN
, ,
and CC
urine NN
protein NN
level NN
were VBD
assessed VBN
at IN
the DT
trial NN
start NN
-LRB- -LRB-
baseline NN
, ,
week NN
0 CD
-RRB- -RRB-
and CC
at IN
week NN
48 CD
. .
The DT
serum NN
creatinine NN
and CC
estimated VBN
glomerular NN
filtration NN
rate NN
-LRB- -LRB-
eGFR NN
-RRB- -RRB-
were VBD
monitored VBN
at IN
each DT
follow-up JJ
point NN
. .

-----
Drug
-----
+++++
NCT01593267
+++++
The DT
authors NNS
report VBP
the DT
3-year JJ
results NNS
of IN
the DT
Barrow NNP
Ruptured NNP
Aneurysm NNP
Trial NNP
-LRB- -LRB-
BRAT NNP
-RRB- -RRB-
. .
The DT
objective NN
of IN
this DT
ongoing JJ
randomized JJ
trial NN
is VBZ
to TO
compare VB
the DT
safety NN
and CC
efficacy NN
of IN
microsurgical JJ
clip NN
occlusion NN
and CC
endovascular NN
coil NN
embolization NN
for IN
the DT
treatment NN
of IN
acutely JJ
ruptured JJ
cerebral JJ
aneurysms NNS
and CC
to TO
compare VB
functional JJ
outcomes NNS
based VBN
on IN
clinical JJ
and CC
angiographic JJ
data NNS
. .
The DT
1-year JJ
results NNS
have VBP
been VBN
previously RB
reported.Two-hundred JJ
thirty-eight JJ
patients NNS
were VBD
assigned VBN
to TO
clip VB
occlusion NN
and CC
233 NN
to TO
coil NN
embolization NN
. .
There EX
were VBD
no DT
anatomical JJ
exclusions NNS
. .
Crossovers NNS
were VBD
allowed VBN
based VBN
on IN
the DT
treating JJ
physician NN
's POS
determination NN
, ,
but CC
primary JJ
outcome NN
analysis NN
was VBD
based VBN
on IN
the DT
initial JJ
assignment NN
to TO
treatment NN
modality NN
. .
Patient JJ
outcomes NNS
were VBD
assessed VBN
independently RB
using VBG
the DT
modified NNP
Rankin NNP
Scale NNP
-LRB- -LRB-
mRS NN
-RRB- -RRB-
. .
A DT
poor JJ
outcome NN
was VBD
defined VBN
as IN
an DT
mRS NN
score VBP
-RRB- -RRB-
2 CD
. .
At IN
3 CD
years NNS
' POS
follow-up JJ
349 CD
patients NNS
who WP
had VBD
actually RB
undergone VBN
treatment NN
were VBD
available JJ
for IN
evaluation NN
. .
Of IN
the DT
170 CD
patients NNS
who WP
had VBD
been VBN
originally RB
assigned VBN
to TO
coiling NN
, ,
64 CD
-LRB- -LRB-
38 CD
% NN
-RRB- -RRB-
crossed VBD
over RP
to TO
clipping NN
, ,
whereas IN
4 CD
-LRB- -LRB-
2 CD
% NN
-RRB- -RRB-
of IN
179 JJ
patients NNS
assigned VBN
to TO
surgery NN
crossed VBN
over RP
to TO
clipping NN
. .
The DT
risk NN
of IN
a DT
poor JJ
outcome NN
in IN
patients NNS
assigned VBN
to TO
clipping VB
compared VBN
with IN
those DT
assigned VBN
to TO
coiling NN
-LRB- -LRB-
35.8 CD
% NN
vs CC
30 CD
% NN
-RRB- -RRB-
had VBD
decreased VBN
from IN
that WDT
observed VBD
at IN
1 CD
year NN
and CC
was VBD
no RB
longer RBR
significant JJ
-LRB- -LRB-
OR NNP
1.30 CD
, ,
95 CD
% NN
CI NN
0.83-2 CD
.04 CD
, ,
p NN
= SYM
0.25 CD
-RRB- -RRB-
. .
In IN
addition NN
, ,
the DT
degree NN
of IN
aneurysm NN
obliteration NN
-LRB- -LRB-
p NN
= SYM
0.0001 CD
-RRB- -RRB-
, ,
rate NN
of IN
aneurysm NN
recurrence NN
-LRB- -LRB-
p NN
= SYM
0.01 CD
-RRB- -RRB-
, ,
and CC
rate NN
of IN
retreatment NN
-LRB- -LRB-
p NN
= SYM
0.01 CD
-RRB- -RRB-
were VBD
significantly RB
better JJR
in IN
the DT
group NN
treated VBN
with IN
clipping VBG
compared VBN
with IN
the DT
group NN
treated VBN
with IN
coiling NN
. .
When WRB
outcomes NNS
were VBD
analyzed VBN
based VBN
on IN
aneurysm NN
location NN
-LRB- -LRB-
anterior NN
circulation NN
, ,
n NN
= SYM
339 CD
; ,
posterior NN
circulation NN
, ,
n NN
= SYM
69 CD
-RRB- -RRB-
, ,
there EX
was VBD
no DT
significant JJ
difference NN
in IN
the DT
outcomes NNS
of IN
anterior NN
circulation NN
aneurysms NNS
between IN
the DT
2 CD
assigned JJ
groups NNS
across IN
time NN
points NNS
-LRB- -LRB-
at IN
discharge NN
, ,
6 CD
months NNS
, ,
1 CD
year NN
, ,
or CC
3 CD
years NNS
after IN
treatment NN
-RRB- -RRB-
. .
The DT
outcomes NNS
of IN
posterior NN
circulation NN
aneurysms NNS
were VBD
significantly RB
better JJR
in IN
the DT
coil NN
group NN
than IN
in IN
the DT
clip NN
group NN
after IN
the DT
1st CD
year NN
of IN
follow-up NN
, ,
and CC
this DT
difference NN
persisted VBD
after IN
3 CD
years NNS
of IN
follow-up NN
. .
However RB
, ,
while IN
aneurysms NNS
in IN
the DT
anterior NN
circulation NN
were VBD
well RB
matched VBN
in IN
their PRP$
anatomical JJ
location NN
between IN
the DT
2 CD
treatment NN
arms NNS
, ,
this DT
was VBD
not RB
the DT
case NN
in IN
the DT
posterior NN
circulation NN
where WRB
, ,
for IN
example NN
, ,
18 CD
of IN
21 CD
posterior JJ
inferior JJ
cerebellar NN
artery NN
aneurysms NNS
were VBD
in IN
the DT
clip NN
group NN
. .
Based VBN
on IN
mRS NN
scores NNS
at IN
3 CD
years NNS
, ,
the DT
outcomes NNS
of IN
all DT
patients NNS
assigned VBN
to TO
coil NN
embolization NN
showed VBD
a DT
favorable JJ
5.8 CD
% NN
absolute JJ
difference NN
compared VBN
with IN
outcomes NNS
of IN
those DT
assigned VBN
to TO
clip VB
occlusion NN
, ,
although IN
this DT
difference NN
did VBD
not RB
reach VB
statistical JJ
significance NN
-LRB- -LRB-
p NN
= SYM
0.25 CD
-RRB- -RRB-
. .
Patients NNS
in IN
the DT
clip NN
group NN
had VBD
a DT
significantly RB
higher JJR
degree NN
of IN
aneurysm NN
obliteration NN
and CC
a DT
significantly RB
lower JJR
rate NN
of IN
recurrence NN
and CC
retreatment NN
. .
In IN
post FW
hoc FW
analysis NN
examining VBG
only RB
anterior JJ
circulation NN
aneurysms NNS
, ,
no DT
outcome NN
difference NN
between IN
the DT
2 CD
treatment NN
cohorts NNS
was VBD
observed VBN
at IN
any DT
recorded VBN
time NN
point NN
. .
CLINICAL NNP
TRIAL NNP
REGISTRATION NNP
NO. NNP
: :
NCT01593267 NN
-LRB- -LRB-
ClinicalTrials NNP
. .
gov VBN
-RRB- -RRB-
. .

-----
Procedure
-----
+++++
NCT01216072
+++++
